CMR Surgical has 6 close competitors: Abridge, Alloy Therapeutics, Benchling.
Sector, valuation and status for each competitor.
company profile›
competitor›
competitor›
competitor›
competitor›
competitor›A private valuation and a public market cap share one column; each row names its basis and date.
CMR SurgicalAbridgeBenchlingCommureDoctolibHeartFlowBritish medical device company that makes the Versius robot-assisted surgery system, offering exposure to a price.
CMR Surgical competes with 6 companies here: Abridge, Alloy Therapeutics, Benchling, Commure, Doctolib, HeartFlow.
CMR Surgical was last valued at $3B (post-money, Apr 2025). That price was agreed in one transaction and holds until the next round. A listed competitor is repriced every trading session.
The last valuation is $3B (post-money, Apr 2025).
Lead investors for each round are in the funding timeline.
The closest medical devices & equipment (surgical robotics) peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.
No. CMR Surgical is a private company; its shares do not trade on a public exchange.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
